Dyne Therapeutics (DYN) Insider Trading & Ownership $15.00 -0.29 (-1.90%) As of 01/14/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Dyne Therapeutics (NASDAQ:DYN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.77%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.06 MNumber OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$57.49 M Get DYN Insider Trade Alerts Want to know when executives and insiders are buying or selling Dyne Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DYN Insider Buying and Selling by Quarter Dyne Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/11/2024Oxana BeskrovnayaInsiderSell2,334$28.12$65,632.08 12/11/2024Richard William ScalzoSVPSell1,455$28.12$40,914.60 11/18/2024Carlo IncertiDirectorSell16,500$28.73$474,045.00 11/14/2024Jason P RhodesDirectorSell782$33.10$25,884.20 10/16/2024Dirk KerstenDirectorSell23,671$35.35$836,769.85 9/25/2024Dirk KerstenDirectorSell2,357$35.06$82,636.42 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/23/2024Dirk KerstenDirectorSell40,831$35.32$1,442,150.92 9/20/2024Dirk KerstenDirectorSell79,411$36.45$2,894,530.95 9/18/2024Oxana BeskrovnayaInsiderSell2,339$34.55$80,812.45 9/18/2024Richard William ScalzoSVPSell1,390$34.55$48,024.50 9/18/2024Susanna Gatti HighCOOSell8,976$34.41$308,864.16 9/4/2024John CoxCEOBuy32,000$33.04$1,057,280.00 6/24/2024Susanna Gatti HighCOOSell10,163$35.33$359,058.79 6/21/2024Susanna Gatti HighCOOSell29,787$35.01$1,042,842.87 6/12/2024Susanna Gatti HighCOOSell40,000$33.36$1,334,400.00 6/11/2024Oxana BeskrovnayaInsiderSell2,136$31.34$66,942.24 6/10/2024Richard William ScalzoSVPSell1,590$30.23$48,065.70 6/10/2024Susanna Gatti HighCOOSell80,000$30.24$2,419,200.00 5/20/2024Oxana BeskrovnayaInsiderSell30,426$32.96$1,002,840.96 5/16/2024Oxana BeskrovnayaInsiderSell2,705$28.27$76,470.35 5/16/2024Richard William ScalzoSVPSell2,588$28.27$73,162.76 5/16/2024Susanna Gatti HighCOOSell2,738$28.27$77,403.26 3/11/2024Joshua T BrummCEOSell66,387$25.67$1,704,154.29 3/11/2024Richard William ScalzoSVPSell2,672$25.28$67,548.16 3/11/2024Susanna Gatti HighCOOSell2,292$25.70$58,904.40 3/11/2024Wildon FarwellInsiderSell1,585$25.70$40,734.50 3/7/2024Joshua T BrummCEOSell9,086$25.85$234,873.10 3/7/2024Oxana BeskrovnayaInsiderSell2,373$25.85$61,342.05 3/7/2024Richard William ScalzoSVPSell2,273$25.85$58,757.05 3/7/2024Susanna Gatti HighCOOSell1,591$25.85$41,127.35 2/29/2024Jonathan McneillInsiderSell4,268$27.50$117,370.00 2/29/2024Joshua T BrummCEOSell5,520$27.50$151,800.00 2/29/2024Richard William ScalzoSVPSell3,429$27.50$94,297.50 2/28/2024Jason P RhodesDirectorSell190,920$24.84$4,742,452.80 2/28/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell154,674$24.84$3,842,102.16 2/26/2024Jason P RhodesDirectorSell248,219$23.72$5,887,754.68 2/26/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell201,095$23.72$4,769,973.40 2/23/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell159,542$22.70$3,621,603.40 2/22/2024Jason P RhodesDirectorSell119,360$22.66$2,704,697.60 2/21/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell184,501$22.57$4,164,187.57 2/20/2024Jason P RhodesDirectorSell169,539$22.72$3,851,926.08 2/16/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell162,707$23.14$3,765,039.98 2/15/2024Jason P RhodesDirectorSell177,906$23.89$4,250,174.34 2/12/2024Wildon FarwellInsiderSell5,493$25.07$137,709.51 1/26/2024Richard William ScalzoSVPSell13,000$24.34$316,420.00 1/26/2024Wildon FarwellInsiderSell100$25.00$2,500.00 (Data available from 1/1/2013 forward) DYN Insider Trading Activity - Frequently Asked Questions Who is on Dyne Therapeutics's Insider Roster? The list of insiders at Dyne Therapeutics includes Carlo Incerti, Dirk Kersten, Jason P Rhodes, John Cox, Jonathan Mcneill, Joshua T Brumm, Oxana Beskrovnaya, Richard William Scalzo, Susanna Gatti High, Venture Fund Xi L.P. Atlas, and Wildon Farwell. Learn more on insiders at DYN. What percentage of Dyne Therapeutics stock is owned by insiders? 20.77% of Dyne Therapeutics stock is owned by insiders. Learn more on DYN's insider holdings. Which Dyne Therapeutics insiders have been buying company stock? The following insiders have purchased DYN shares in the last 24 months: Dirk Kersten ($29,999,987.50), and John Cox ($1,057,280.00). How much insider buying is happening at Dyne Therapeutics? Insiders have purchased a total of 1,746,285 DYN shares in the last 24 months for a total of $31,057,267.50 bought. Which Dyne Therapeutics insiders have been selling company stock? The following insiders have sold DYN shares in the last 24 months: Carlo Incerti ($474,045.00), Dirk Kersten ($5,256,088.14), Jason P Rhodes ($21,462,889.70), Jonathan Mcneill ($257,670.00), Joshua T Brumm ($9,525,034.91), Oxana Beskrovnaya ($2,214,327.61), Richard William Scalzo ($1,215,649.45), Susanna Gatti High ($5,815,817.04), Venture Fund Xi L.P. Atlas ($20,162,906.51), and Wildon Farwell ($198,713.88). How much insider selling is happening at Dyne Therapeutics? Insiders have sold a total of 2,861,566 Dyne Therapeutics shares in the last 24 months for a total of $66,583,142.24 sold. Dyne Therapeutics Key ExecutivesMs. Susanna Gatti High M.B.A. (Age 56)Chief Operating Officer Compensation: $754.1k1 recent tradesDr. Jonathan McNeill M.D. (Age 39)Chief Business Officer Compensation: $662.34kMr. John G. Cox M.B.A. (Age 61)CEO, President & Director Dr. Romesh Subramanian Ph.D. (Age 59)Co-Founder & Advisor Compensation: $565.17kMr. Richard William Scalzo M.B.A. (Age 38)Senior VP and Head of Finance & Administration 2 recent tradesMr. John Najim M.B.A.Chief Technical OfficerDr. Oxana Beskrovnaya Ph.D. (Age 63)Chief Scientific Officer Compensation: $631.08kMs. Amy Reilly (Age 50)Senior VP and Head of Corporate Communications & Investor Relations Mr. Daniel Wilson (Age 52)Senior VP & Head of Legal Ms. Kate MitchellVP & Head of Human Resources More Insider Trading Tools from MarketBeat Related Companies ELAN Insider Ownership CYTK Insider Ownership NUVL Insider Ownership GRFS Insider Ownership TGTX Insider Ownership VKTX Insider Ownership AXSM Insider Ownership KRYS Insider Ownership OGN Insider Ownership ADMA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher This page (NASDAQ:DYN) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyne Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DYN Stock Alerts